Combined Effect of Midazolam and Bone Morphogenetic Protein-2 for Differentiation Induction from C2C12 Myoblast Cells to Osteoblasts
In drug repositioning research, a new concept in drug discovery and new therapeutic opportunities have been identified for existing drugs. Midazolam (MDZ) is an anesthetic inducer used for general anesthesia. Here, we demonstrate the combined effects of bone morphogenetic protein-2 (BMP-2) and MDZ o...
Saved in:
Main Authors: | Yukihiko Hidaka (Author), Risako Chiba-Ohkuma (Author), Takeo Karakida (Author), Kazuo Onuma (Author), Ryuji Yamamoto (Author), Keiko Fujii-Abe (Author), Mari M. Saito (Author), Yasuo Yamakoshi (Author), Hiroshi Kawahara (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2020-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Characterization of bioactive substances involved in the induction of bone augmentation using demineralized bone sheets
by: Haruka Saito, et al.
Published: (2022) -
Nitric Oxide Induces Apoptosis in Mouse C2C12 Myoblast Cells
by: Myoung-Hwa Lee, et al.
Published: (2005) -
Vitamin C Activates the Folate-Mediated One-Carbon Cycle in C2C12 Myoblasts
by: Armando Alcazar Magana, et al.
Published: (2020) -
Curcumin Ameliorated Oxidative Stress and Inflammation-Related Muscle Disorders in C2C12 Myoblast Cells
by: Da-Yeon Lee, et al.
Published: (2021) -
Effects of alpha-linolenic acid and essential amino acids on the proliferation and differentiation of C2C12 myoblasts
by: Dongjie Zhou, et al.
Published: (2022)